Skip to content
10-Q

Quarterly Report

Protagonist Therapeutics, Inc PTGX

0001104659-25-107816

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 29, 2025 62.52M sh
Shares Diluted Q3 2025 · Sep 30, 2025 63.77M sh
Shares Diluted Q3 2025 · Sep 30, 2025 63.42M sh
Shares Diluted Q3 2025 · Sep 30, 2024 61.77M sh
Shares Diluted Q3 2025 · Sep 30, 2024 64.61M sh
Capex Q3 2025 · Sep 30, 2025 $1.45M
Capex Q3 2025 · Sep 30, 2024 $1.05M
Operating Cash Flow Q3 2025 · Sep 30, 2025 $94.65M
Operating Cash Flow Q3 2025 · Sep 30, 2024 $213.33M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $113.71M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $97.25M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $131.12M
Stockholders Equity Q3 2025 · Sep 30, 2025 $645.44M
Stockholders Equity Q3 2025 · Jun 30, 2025 $668.02M
Stockholders Equity Q3 2025 · Dec 31, 2024 $675.3M
Stockholders Equity Q3 2025 · Sep 30, 2024 $531.92M
Stockholders Equity Q3 2025 · Jun 30, 2024 $541.32M
Stockholders Equity Q3 2025 · Dec 31, 2023 $336.68M
Current Liabilities Q3 2025 · Sep 30, 2025 $44.94M
Current Liabilities Q3 2025 · Dec 31, 2024 $47.4M
Total Liabilities Q3 2025 · Sep 30, 2025 $56.25M
Total Liabilities Q3 2025 · Dec 31, 2024 $69.43M
Current Assets Q3 2025 · Sep 30, 2025 $586.42M
Current Assets Q3 2025 · Dec 31, 2024 $591.64M
Total Assets Q3 2025 · Sep 30, 2025 $701.69M
Total Assets Q3 2025 · Dec 31, 2024 $744.73M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.62
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.35
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.54
Eps Diluted Q3 2025 · Sep 30, 2024 $2.22
Eps Basic Q3 2025 · Sep 30, 2025 −$0.62
Eps Basic Q3 2025 · Sep 30, 2025 −$1.35
Eps Basic Q3 2025 · Sep 30, 2024 −$0.54
Eps Basic Q3 2025 · Sep 30, 2024 $2.34
Sga Expense Q3 2025 · Sep 30, 2025 $11.13M
Sga Expense Q3 2025 · Sep 30, 2025 $33.42M
Sga Expense Q3 2025 · Sep 30, 2024 $10.16M
Sga Expense Q3 2025 · Sep 30, 2024 $34.51M
Rd Expense Q3 2025 · Sep 30, 2025 $40M
Rd Expense Q3 2025 · Sep 30, 2025 $112.93M
Rd Expense Q3 2025 · Sep 30, 2024 $35.97M
Rd Expense Q3 2025 · Sep 30, 2024 $103.22M
Net Income Q3 2025 · Sep 30, 2025 −$39.34M
Net Income Q3 2025 · Sep 30, 2025 −$85.77M
Net Income Q3 2025 · Sep 30, 2024 −$33.21M
Net Income Q3 2025 · Sep 30, 2024 $143.51M
Operating Income Q3 2025 · Sep 30, 2025 −$46.42M
Operating Income Q3 2025 · Sep 30, 2025 −$107.77M
Operating Income Q3 2025 · Sep 30, 2024 −$41.45M
Operating Income Q3 2025 · Sep 30, 2024 $126.06M